Prestige Consumer Healthcare Inc
PBH61.540USD
+1.080+1.79%
Horarios del mercado （ET）Cotizaciones retrasadas 15 min
2.96BCap. mercado
14.73P/E TTM
Más Datos de Prestige Consumer Healthcare Inc Compañía
Prestige Consumer Healthcare Inc. is consumer healthcare products company. The Company is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (OTC) health and personal care products to mass merchandisers, drug, food, dollar, convenience, club and e-commerce stores in North America (the United States and Canada) and in Australia and certain other international markets. It operates through two segments: North American OTC Healthcare and International OTC Healthcare. Its diverse portfolio of brands includes Monistat and Summer’s Eve women's health products, BC and Goody's pain relievers, Clear Eyes and TheraTears eye care products, DenTek specialty oral care products, Dramamine motion sickness treatments, Fleet enemas and glycerin suppositories, Chloraseptic and Luden's sore throat treatments and drops, Compound W wart removal products, Boudreaux’s Butt Paste diaper rash ointments, Nix lice treatment products, Debrox earwax remover, and others.
Información de Prestige Consumer Healthcare Inc
Símbolo de cotizaciónPBH
Nombre de la empresaPrestige Consumer Healthcare Inc
Fecha de salida a bolsaFeb 10, 2005
Director ejecutivoMr. Ronald M. (Ron) Lombardi, CPA
Número de empleados600
Tipo de seguridadOrdinary Share
Fin del año fiscalFeb 10
Dirección660 White Plains Rd.
CiudadTARRYTOWN
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal10591
Teléfono19145246800
Sitio Webhttps://www.prestigebrands.com/
Símbolo de cotizaciónPBH
Fecha de salida a bolsaFeb 10, 2005
Director ejecutivoMr. Ronald M. (Ron) Lombardi, CPA
Ejecutivos de Prestige Consumer Healthcare Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Ronald M. (Ron) Lombardi, CPA
Mr. Ronald M. (Ron) Lombardi, CPA
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
355.35K
-10.40%
Ms. Christine (Chris) Sacco, CPA
Ms. Christine (Chris) Sacco, CPA
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
63.23K
-32.80%
Mr. John E. Byom
Mr. John E. Byom
Lead Independent Director
Lead Independent Director
52.39K
+4.16%
Mr. William C. P'Pool, J.D.
Mr. William C. P'Pool, J.D.
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
35.30K
+10.28%
Mr. Jeffrey Zerillo
Mr. Jeffrey Zerillo
Senior Vice President - Operations
Senior Vice President - Operations
35.20K
+6.66%
Ms. Sheila A. Hopkins
Ms. Sheila A. Hopkins
Independent Director
Independent Director
27.92K
+8.11%
Mr. Adel Mekhail
Mr. Adel Mekhail
Executive Vice President - Marketing & Sales
Executive Vice President - Marketing & Sales
15.16K
-30.95%
Ms. Dawn M. Zier
Ms. Dawn M. Zier
Independent Director
Independent Director
14.33K
+17.11%
Dr. Celeste A. Clark, Ph.D.
Dr. Celeste A. Clark, Ph.D.
Independent Director
Independent Director
11.33K
+22.68%
Mr. James C. D'arecca
Mr. James C. D'arecca
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Ronald M. (Ron) Lombardi, CPA
Mr. Ronald M. (Ron) Lombardi, CPA
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
355.35K
-10.40%
Ms. Christine (Chris) Sacco, CPA
Ms. Christine (Chris) Sacco, CPA
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
63.23K
-32.80%
Mr. John E. Byom
Mr. John E. Byom
Lead Independent Director
Lead Independent Director
52.39K
+4.16%
Mr. William C. P'Pool, J.D.
Mr. William C. P'Pool, J.D.
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
35.30K
+10.28%
Mr. Jeffrey Zerillo
Mr. Jeffrey Zerillo
Senior Vice President - Operations
Senior Vice President - Operations
35.20K
+6.66%
Ms. Sheila A. Hopkins
Ms. Sheila A. Hopkins
Independent Director
Independent Director
27.92K
+8.11%
Desglose de ingresos
Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
Sin datos
Por regiónUSD
Nombre
Ganancia
Proporción
United States
897.54M
78.89%
Rest of world
240.22M
21.11%
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: vie., 17 de oct
Actualizado: vie., 17 de oct
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
14.62%
The Vanguard Group, Inc.
11.40%
Dimensional Fund Advisors, L.P.
5.14%
Ariel Investments, LLC
4.58%
State Street Investment Management (US)
4.16%
Otro
60.10%
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
14.62%
The Vanguard Group, Inc.
11.40%
Dimensional Fund Advisors, L.P.
5.14%
Ariel Investments, LLC
4.58%
State Street Investment Management (US)
4.16%
Otro
60.10%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
66.27%
Investment Advisor/Hedge Fund
30.99%
Research Firm
3.47%
Hedge Fund
1.89%
Pension Fund
1.33%
Individual Investor
1.29%
Sovereign Wealth Fund
1.12%
Family Office
0.61%
Bank and Trust
0.53%
Participación institucional
Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
667
52.11M
108.37%
-2.03M
2025Q2
667
53.74M
109.15%
-2.00M
2025Q1
670
54.01M
109.68%
-1.79M
2024Q4
653
54.79M
110.61%
+365.71K
2024Q3
633
53.04M
107.02%
-1.71M
2024Q2
622
53.11M
106.92%
-2.21M
2024Q1
614
53.06M
106.87%
-2.26M
2023Q4
602
52.89M
106.58%
-3.51M
2023Q3
590
52.77M
106.53%
-2.81M
2023Q2
589
51.93M
104.86%
-4.95M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
BlackRock Institutional Trust Company, N.A.
7.03M
14.28%
-239.29K
-3.29%
Jun 30, 2025
The Vanguard Group, Inc.
5.62M
11.42%
-2.89K
-0.05%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
2.47M
5.02%
-244.43K
-9.00%
Jun 30, 2025
Ariel Investments, LLC
2.20M
4.47%
-316.61K
-12.57%
Jun 30, 2025
State Street Investment Management (US)
2.00M
4.06%
+1.65K
+0.08%
Jun 30, 2025
Macquarie Investment Management
1.97M
4%
-285.27K
-12.66%
Jun 30, 2025
Kayne Anderson Rudnick Investment Management, LLC
1.75M
3.55%
+168.12K
+10.64%
Jun 30, 2025
Allspring Global Investments, LLC
1.52M
3.09%
-94.00K
-5.82%
Jun 30, 2025
Geode Capital Management, L.L.C.
1.41M
2.87%
+9.46K
+0.67%
Jun 30, 2025
Goldman Sachs Asset Management, L.P.
949.09K
1.93%
+534.84K
+129.11%
Jun 30, 2025
Ver más
ETFs relacionados
Actualizado: jue., 6 de nov
Actualizado: jue., 6 de nov
Nombre
Proporción
Invesco Pharmaceuticals ETF
2.51%
Schwab Ariel Opportunities ETF
2.33%
SPDR S&P Pharmaceuticals ETF
2.31%
Invesco S&P SmallCap Health Care ETF
1.95%
Congress SMid Growth ETF
1.92%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
1.73%
iShares U.S. Pharmaceuticals ETF
1.13%
Brandes US Small-Mid Cap Value ETF
0.86%
JPMorgan Active Small Cap Value ETF
0.72%
Invesco S&P SmallCap Low Volatility ETF
0.63%
Ver más
Invesco Pharmaceuticals ETF
Proporción2.51%
Schwab Ariel Opportunities ETF
Proporción2.33%
SPDR S&P Pharmaceuticals ETF
Proporción2.31%
Invesco S&P SmallCap Health Care ETF
Proporción1.95%
Congress SMid Growth ETF
Proporción1.92%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
Proporción1.73%
iShares U.S. Pharmaceuticals ETF
Proporción1.13%
Brandes US Small-Mid Cap Value ETF
Proporción0.86%
JPMorgan Active Small Cap Value ETF
Proporción0.72%
Invesco S&P SmallCap Low Volatility ETF
Proporción0.63%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
